1
A Randomized, Double-blind, Placebo-controlled, Safety and Efficacy Study of VI-0106 (Extended-release Tacrolimus) in Subjects with PAH and Functional Limitations despite Optimized Treatment with Available PAH Medications (Sponsor: Vivus LLC)
2
Phase 2bA Phase 2b, Randomized, Double-blind, Placebo-Controlled Trial of IKT-001 in Pulmonary Arterial Hypertension (Sponsor: Inhibikase Therapeutics)
ClinicalTrials.govNCT066431433
Phase 2A Phase 2, Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of ARGX-121 in Adult Participants with IgA Nephropathy (Sponsor: Argenx)